1992
DOI: 10.1097/00004583-199211000-00027
|View full text |Cite
|
Sign up to set email alerts
|

Clomipramine Treatment of Stereotypic Behaviors and Self-Injury in Patients with Developmental Disabilities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
13
0

Year Published

1993
1993
2014
2014

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 64 publications
(13 citation statements)
references
References 10 publications
0
13
0
Order By: Relevance
“…The tricyclic antidepressant and non-selective but potent SRI clomipramine produced a marked decrease in stereotypic behaviors and self-injury in 10 of 11 subjects with ID in an open-label trial (Garber et al 1992). A subsequent double-blind, placebo-controlled crossover study yielded similar results, with a clinically significant reduction in the frequency of SIB in 6 of 8 adults with ID.…”
Section: Srismentioning
confidence: 76%
“…The tricyclic antidepressant and non-selective but potent SRI clomipramine produced a marked decrease in stereotypic behaviors and self-injury in 10 of 11 subjects with ID in an open-label trial (Garber et al 1992). A subsequent double-blind, placebo-controlled crossover study yielded similar results, with a clinically significant reduction in the frequency of SIB in 6 of 8 adults with ID.…”
Section: Srismentioning
confidence: 76%
“…In treatmentresistant cases, other serotonergic anti depressant agents such as clomipramine may be effective (Garber 1992).…”
Section: Antidepressants and Anxiolyticsmentioning
confidence: 99%
“…These authors observed that clomipramine treatment was associated with improvement in the intensity of SIB, the frequency of stereotypy and compulsions, and a decrease in staff-reported interventions for problem behaviours. Garber et al (1992) demonstrated that clomipramine was effective in decreasing chronic stereotypic and SIB such as head banging, head and face slapping, arm biting, eye gouging, aggression and tantrums in 10 out of 11 adolescents with developmental disorders. In a prospective open trial of clomipramine, Brodkin et al (1997) observed that 55 % of the 33 adults with Pervasive Developmental Disorder who completed the 12-wk trial were treatment responders, with clomipramine reducing repetitive thoughts and behaviours, aggression and improving social responsiveness.…”
Section: Introductionmentioning
confidence: 99%